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Abstract
We tested the hypothesis that the anti-inflammatory actions of atrial natri-
uretic peptide (ANP) result from the modulation of leukocyte adhesion to
inflamed endothelium and not solely ANP ligation of endothelial receptors to
stabilize endothelial barrier function. We measured vascular permeability to
albumin and accumulation of fluorescent neutrophils in a full-thickness skin
wound on the flank of LysM-EGFP mice 24 h after formation. Vascular per-
meability in individually perfused rat mesenteric microvessels was also mea-
sured after leukocytes were washed out of the vessel lumen. Thrombin
increased albumin permeability and increased the accumulation of neu-
trophils. The thrombin-induced inflammatory responses were attenuated by
pretreating the wound with ANP (30 min). During pretreatment ANP did not
lower permeability, but transiently increased baseline albumin permeability
concomitant with the reduction in neutrophil accumulation. ANP did not
attenuate acute increases in permeability to histamine and bradykinin in indi-
vidually perfused rat microvessels. The hypothesis that anti-inflammatory
actions of ANP depend solely on endothelial responses that stabilize the
endothelial barrier is not supported by our results in either individually per-
fused microvessels in the absence of circulating leukocytes or the more
chronic skin wound model. Our results conform to the alternate hypothesis
that ANP modulates the interaction of leukocytes with the inflamed microvas-
cular wall of the 24 h wound. Taken together with our previous observations
that ANP reduces deformability of neutrophils and their strength of attach-
ment, rolling, and transvascular migration, these observations provide the
basis for additional investigations of ANP as an anti-inflammatory agent to
modulate leukocyte–endothelial cell interactions.
Introduction
The primary homeostatic action of atrial natriuretic pep-
tide (ANP) in the microcirculation is to increase endothe-
lial barrier permeability to plasma proteins when plasma
volume is increased. These microvascular actions act in
parallel with the well-known renal functions as a natriuretic
and diuretic. Recent published data has drawn attention to
additional actions of ANP which may be vasoprotective.
These include actions of ANP as a vasodilator to improve
perfusion and as a modulator of the immune system. The
combination of functions as a vasodilator, diuretic, and
possible immune modulator has increased interest in the
use of ANP analogs to improve vascular functions in a clin-
ical setting. For example, in Japan there are ongoing clini-
cal trials in patients with various forms of acute and
chronic heart failure (Suwa et al. 2005; Mitaka et al. 2011;
Mori et al. 2014). In addition, several investigations, par-
ticularly those using cultured endothelial cell monolayers
as model systems, suggest ANP may activate anti-
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
2016 | Vol. 4 | Iss. 18 | e12968
Page 1
Physiological Reports ISSN 2051-817X
inflammatory mechanisms: one line of investigation sug-
gests that ANP may attenuate inflammatory responses via a
variety of mechanisms, including stabilizing the endothelial
cell cytoskeleton via cAMP, cGMP, and Rac/Rho activation
under a range of experimental conditions (Klinger et al.
2006; Surapisitchat et al. 2007; Birukova et al. 2008; Xing
and Birukova 2010); attenuating calcium influx (Kiemer
et al. 2002; Furst et al. 2008; Chen et al. 2013); or reducing
generation of proinflammatory agents (e.g., ROS) from
activated endothelium, neutrophils, or mast cells or other
inflammatory cells (Vollmar 2005; Kuhn 2012; Chen et al.
2013).
Another line of investigation focuses on the role of
ANP in reducing leukocyte/endothelial interactions. Sev-
eral studies suggest ANP limits activation of Nf-kappa B,
and reduces ischemic reperfusion injury (el Mtairag et al.
2002; Vollmar 2005; Ladetzki-Baehs et al. 2007; Chujo
et al. 2008). In our laboratory, we have recently demon-
strated that ANP reduced accumulation of polymor-
phonuclear leukocytes (PMNs) in a mouse skin wound
after exogenous thrombin was added to the wound (Mor-
ikis et al. 2015). In the latter study we demonstrated that
the mechanism of action of ANP, added at concentrations
within the physiological and pathophysiological range (1–
10 nmol/L), involved an attenuation of PMN rolling,
adhesion, and transendothelial migration by reducing
their deformability and limiting the area of adhesive con-
tact with the endothelium (Morikis et al. 2015). Despite
the range of investigations on the relative influence of
ANP on PMN-dependent and endothelial-dependent
inflammation, studies of its affect on intact microvascular
beds have been less well studied. There is a particular
need for investigations of the action of ANP to modify
vascular permeability and endothelial/leukocyte interac-
tions evaluated simultaneously.
The aim of this study was to employ two established
models of vascular permeability modulation to investigate
the role of ANP in attenuating increased vascular perme-
ability in microvessels under conditions where PMN
interaction with the microvascular wall is detected and
manipulated. One model is the full-thickness skin wound
on the back of lysM-EGFP knock-in mouse whose mature
circulating PMN express EGFP. This model enables the
measurement of both PMN accumulation and changes in
permeability by whole animal fluorescence detection of
labeled albumin simultaneously with the EGFP signal
from the wound bed. We investigated the action of ANP
to modulate thrombin-induced hyperpermeability and
PMN accumulation in a full-thickness skin wound on the
mouse flank. These experiments were performed under
identical conditions as our published studies, where ANP
was found to reduce PMN accumulation during acute
thrombin activation of a 24-h skin wound (Kim et al.
2009; Morikis et al. 2015). In a second in vivo model, we
evaluated the action of ANP to modulate acute inflamma-
tory responses to histamine and bradykinin addition in
individually perfused rat venular microvessels with no
prior exposure to inflammation. In these vessels blood
was washed out of the vessel lumen at the beginning of
the experiment so that the action of ANP was tested in
the absence of arrested or rolling leukocytes.
Our results conform to the hypothesis that ANP may
act as an anti-inflammatory agent under conditions of
sustained inflammation such as those in a full-thickness
skin wound. We conclude that the mechanism of action
of ANP is primarily through modulation of leukocyte/en-
dothelial interactions. This finding is consistent with
in vitro experiments that reveal ANP acts to decrease
PMN deformability and shear resistant arrest on inflamed
endothelium in shear flow. Furthermore, ANP did not
significantly attenuate an acute increase in permeability in
individually perfused microvessels exposed to either bra-
dykinin or histamine in the absence of leukocytes.
Methods
Animals
Mice stably expressing the lysM-EGFP gene were gener-
ated by cross-breeding 129Sv lysM-EGFP mice (gener-
ously provided by Dr. Thomas Graf, Albert Einstein
College of Medicine, Bronx, NY) with C57BL/6J (Jackson,
Bar Harbor, ME) for at least nine generations in the ani-
mal facility at University of California at Davis and were
housed in the same facility. Experiments in the 24 h
wound were carried out in male and female mice between
8 and 12 weeks of age in all the experiments. Mice were
anesthetized with an intraperitoneal injection of ketamine
(80 mg/kg)-xylazine (10 mg/kg), and the back skin hair
was then removed with a mechanical shaver. After steril-
ization with 10% wt/vol povidine-iodine and 70% alco-
hol, 6 mm in diameter circular full-thickness wound was
made using a skin biopsy punch (Robbins Instruments,
Chatham, NJ). All mouse experiments were approved by
the Institutional Animal Care and Use Committee of the
University of California at Davis (animal protocol nos
11777 and 13386). Experiments to measure albumin per-
meability coefficients and hydraulic conductivity were car-
ried out on male rats (Harlan Sprague–Dawley, 350–
450 g); anesthetized with pentobarbital (100 mg/kg body
wt. sc); and maintained with additional pentobarbital
(30 mg/kg sc) as determined using toe-pinch reflex. At
the end of experiments animals were euthanized with sat-
urated KCl. Animal protocols (no. 16158) were approved
by the Institutional Animal Care and Use Committee of
the University of California, Davis.
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In vivo whole animal fluorescence imaging
of neutrophils and AlexaFluor-BSA
The in vivo imaging of fluorescence-tagged BSA and
EGFP-PMN on the flank of mice with skin wounds was
performed using a commercial whole animal fluorescence
imaging system (Xenogen IVIS 100 system, Perkin Elmer
Waltham, MA), as previously described (Kim et al. 2008).
Mice were put into the imaging chamber of the system
after being anesthetized by ketamine-xylazine. EGFP-
PMN within the wound area were visualized using a GFP
filter (excitation at 445–490 nm and emission at 515–
575 nm) at an exposure time of 1 sec. Simultaneous
imaging of BSA-AlexaFluor 680 within the wound area
was achieved with BSA-AlexaFluor 680 with a CY5.5 filter
(excitation at 615–665 nm and emission at 695–770 nm,
at an exposure time of 1 sec). BSA-Alexa 594 within the
wound area was imaged using DsRed filter (excitation at
500–550 nm and emission at 575–650 nm, at an exposure
time of 1 sec). Analysis of the images was performed
using Live Image Pro. 2.5 software (Caliper Life Sciences,
Hopkinton, MA), and fluorescence intensities expressed
as average radiance (photons per cm2 per steradian) were
measured by drawing a circular region of interest over
the entire wound area. Figure 1 illustrates the mouse
imaging methods. Fluorescently labeled albumin extrava-
sation into skin wounds was detected after intravenous
tail vein administration of fluorescence-conjugated albu-
min as a tracer. Apparent albumin permeability (P) was
quantified based on the previously described linear rela-
tionship between the measured fluorescence intensity (I)
and the concentration of fluorescently conjugated albumin
within the wound area. Ps = 1/DI(0) (dI/dt) (r/2), where
DI(0) is the step increase in fluorescence of tracer molecules
due to vascular filling, dI/dt is the rate of albumin extrava-
sation into the surrounding tissue, and r is the average
radius of the postcapillary venules. As previously described
(Kim et al. 2009), a value of r = 12.5 lm was used as a
median value for postcapillary venules with diameters 10–
40 lm. To a first approximation, the method accounts for
changes in surface area for exchange provided the local
microvascular plasma volume to microvessel exchange sur-
face ratio remains constant. This is assumed to be valid
even under conditions of vasodilation or vasoconstriction
contemporaneous with shifts in tissue permeability as pre-
viously described (Curry et al. 2010).
Measurement of albumin permeability
coefficient and hydraulic conductivity in
individually perfused rat mesenteric venules
Our well-established methods in rat microvessels were
used for these experiments, as there are very few
microvessels in mouse mesentery suitable for microperfu-
sion. The methods have been described in detail elsewhere
(Curry et al. 2012). Briefly, the mesentery was continu-
ously superfused with Ringer’s solution (35–37°C). Exper-
iments were performed on straight nonbranched segments
of venular microvessels typically of 25–35 lm diameter.
The mesentery was observed via transillumination using a
209 (0.5 numerical aperture) long-working distance lens
(Zeiss Axiovert 100M microscope, Dublin, CA) and
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Figure 1. Schematic showing the methods to measure changes in either the fluorescence intensity (FI, photons/sec/cm2/sr) from either EGFP-
labeled polymorphonuclear leukocytes (PMNs) or albumin labeled with the long wavelength fluorescent Alexa-680 in the back skin wound of
an anesthetized mouse. The apparent permeability coefficient of the labeled albumin is measured from the step increase in FI as the tracer is
injected into the tail vein and the subsequent increase in FI as the tracer accumulates in the tissue. This arrangement enabled us to
demonstrate that atrial natriuretic peptide increases the apparent albumin permeability in the 24-h skin wound under the same conditions that
decreased PMNs in the wound and thrombin induced further accumulation in the 24 h wound (Morikis et al. 2015).
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venular microvessels cannulated using a double-barreled
(h) pipette to enable perfusion with either a control
(non-fluorescent) solution containing BSA (10 mg/mL)
and red cells 1.5% hematocrit to maintain normal base-
line permeability (Curry et al. 2012), or the same per-
fusate containing Alexa Fluor 595-labeled BSA (0.5–1 mg/
mL). Fluorescent intensity (If) was measured using a
high-sensitivity camera (Hamamatsu EM CCD C9100,
Hamamatsu, Japan) every 500 msec (30 msec exposure)
and saved for offline analysis. Apparent Ps was calculated
as above from the expression: Ps = [1/DI(0)] (dI/dt) (r/
2). Hydraulic conductivity (Lp) was measured using the
modified Landis technique, which measures the volume
flux of water crossing the wall of a microvessel perfused
via a glass micropipette following downstream occlusion
of the vessel (Michel et al. 1974; Kendall and Michel
1995; Michel and Curry 1999; Adamson et al. 2010; Curry
et al. 2015). The initial transcapillary water flow per unit
area of the capillary wall (Jv/S)0 was measured at prede-
termined capillary pressures of 30–60 cmH2O. Microves-
sel Lp was calculated as the slope of the relation between
(Jv/S) and applied hydraulic pressure. Lp was estimated
from each occlusion with the assumption that the net
effective pressure determining fluid flow was equal to the
applied hydraulic pressure minus 3.6 cmH2O, the approx-
imate oncotic pressure contributed by the BSA in all per-
fusates. Experimental reagents were added to the
superfusate and delivered continuously during both Ps
and Lp measurement.
ANP delivery to wound: estimate of
effective concentration
In previous investigations using exogenous ANP in mouse,
we and other investigators have infused ANP at a rate of
0.5 ng/g BW/min (500 ng/kgBW/min) i.v. to maintain a
plasma concentration close to 1 ng/mL (Sabrane et al.
2005; Lin et al. 2011). Thus, the average whole-body degra-
dation of ANP in normal conditions appears to be close to
0.5 ng/g BW/min. Assuming skin and muscle are 40%
body weight, this degradation rate is 1.25 ng/g/min in
these tissues. In this experiment we added ANP directly to
the wound at rates between 1 and 1.5 ng/min (mean
1.25 ng/min; applied as 6 ng in 10 ll every 5 min). The
average ANP concentration in the wound depends on the
distribution volume for the added ANP, and the actual rate
of degradation of ANP in the wound (which we expected
to be higher than the normal average because of the
inflammatory conditions). If the rate of degradation of
ANP in the wound (6 mm diameter and ~300 lm depth)
is between 2 and 10 times normal, the average ANP con-
centration is predicted to fall in the range ~3–30 ng/mL
(1–10 nmol/L). This range is identical to that previously
used to record reduced leukocyte deformability and
endothelial arrest in vitro (Morikis et al. 2015). Circulating
ANP concentrations are markedly elevated under patho-
physiological conditions (Joseph et al. 2013).
Atrial natriuretic peptide was added to the superfusate
for all experiments in individually perfused rat mesentery
microvessels. When low ANP concentrations (1–10 nmol/
L) had no effect to modulate histamine responses, we
increased ANP to the much higher concentrations (100–
1000 nmol/L) to test the same range over which in vitro
experiments with ANP demonstrated modulation of his-
tamine responses (Furst et al. 2008; Chen et al. 2013).
Analysis and statistics
The nonparametric Mann–Whitney test was used to com-
pare pairwise unmatched groups having unknown vari-
ances. For repeated measures data we used the
nonparametric Friedman test. For the comparison of a
single group to a null hypothesis the F-test was used.
Where matched pairwise data were available, a nonpara-
metric Wilcoxon test was applied. In all cases, significance
was assumed for probability of less than 0.05. Averaged
values are reported throughout as mean  SEM.
Results
Thirty minutes pretreatment with ANP
attenuates the acute thrombin-induced
increase in permeability in a skin wound
produced 24 h previous
Baseline permeability to albumin in the vasculature sur-
rounding a full-thickness skin wound was first measured
with AlexaFluor 595 dye labeled albumin, resulting in a
mean control Ps
BSA of 7.5  0.4 9 107 cm/sec. Throm-
bin (5 U/mL) was then perfused directly into the wound
and albumin labeled with AlexaFluor 680 was i.v. injected
simultaneously. Figure 2A depicts the thrombin-induced
increase in apparent permeability coefficient to BSA
(Ps
BSA) in a skin wound produced 24 h previous. The
peak Ps
BSA after 10 min exposure to thrombin was
increased by 1.8  0.1 times relative to control
(13.9  1.0 9 107 cm/sec, n = 9; P < 0.05, Mann–
Whitney).
Pretreatment of the wound with ANP (1.25 ng/min) for
30 min followed by 10 min of perfusion with thrombin
resulted in a mean Ps
BSA680 of 9.3  0.8 9 107 cm/sec
(Fig. 2B). This value was not significantly different from
control values measured prior to ANP treatment or ANP
plus thrombin (Mann–Whitney) and was significantly less
than the thrombin-induced PBSA in the absence of ANP
(Fig. 2A, Mann–Whitney). In additional experiments when
2016 | Vol. 4 | Iss. 18 | e12968
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ANP was washed out for 30 min after combined treatment
with ANP and thrombin, PBSA was 15.1  2.6 9 107 cm/
sec indicating that the action of ANP to attenuate the
thrombin response was reversible. Furthermore, a pretreat-
ment period of at least 30 min with ANP was required in
order to observe attenuation of the thrombin-induced
increase in permeability. This was confirmed in six addi-
tional experiments where ANP was added at the same time
as thrombin, the action of ANP to attenuate the thrombin-
induced increase in PBSA was not statistically different from
PBSA with thrombin alone.
ANP acutely increases vascular permeability
under the same conditions that it
attenuates thrombin-induced increase in
permeability
To test the hypothesis that ANP stabilized the endothelial
barrier to changes in permeability, we measured PBSA in
the wound when ANP was applied to a skin wound and no
thrombin was added. The experiments in Figure 3 show
that ANP (1.25 g/min) treatment alone induced an
increase in apparent permeability to BSA-Alexa680 (Ps
BSA)
in mouse skin wounds made 24 h previous. Baseline per-
meability in the skin wound vasculature measured with
Alexa 595 labeled albumin was 7.8  0.7 9 107 cm/sec.
ANP was then applied to the wound and Alexa 680 labeled
albumin was injected simultaneously. The peak Ps
BSA after
10 min exposure to ANP (12.1  1.1 9 107 cm/sec) was
significantly increased relative to controls (Friedman test,
with Dunn’s multiple comparison post-test, P < 0.05 dif-
ferent from control, n = 12). Albumin permeability
returned to control values over ~20 min. There was no sig-
nificant difference between the initial control permeability
and that measured at the end of the ANP application
(20 min). Thus, ANP increases the permeability of
microvessels in wounds under the same conditions that
preconditioning by ANP attenuated thrombin-induced
permeability. Thus, there was no evidence that ANP stabi-
lized the vascular wall to changes in permeability by known
mechanisms such as an increase in intracellular cAMP.
The fractional increase in PBSA induced by wound
treatment with ANP was similar to that elicited by
ANP in the mouse skin without a wound (Curry et al.
2010; Lin et al. 2011). In fact in four additional ani-
mals pretreated for 30 min with the phosphodiesterase
4 (PDE4) inhibitor rolipram 8 mg/kg, ANP failed to
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Figure 2. Atrial natriuretic peptide (ANP) attenuates the thrombin-induced increase in apparent permeability coefficient to albumin. (A) Peak
permeability at 10 min is significantly higher than control measured 24 h after the wound was formed (n = 9 Thr and n = 16 ctl; P < 0.05,
Mann–Whitney). (B) After 30 min pretreatment with ANP (1.25 ng/min) directly into the wound the apparent albumin permeability coefficient
is not significantly different from the control (n = 7 Thr/ANP and n = 16 ctl; P > 0.08; Mann–Whitney), but significantly less than thrombin
alone (n = 9 Thr, n = 7ctl; P < 0.05; Mann–Whitney).
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Figure 3. Measurement of apparent albumin permeability
coefficient during the 30-min period after atrial natriuretic peptide
(ANP) is applied to the wound before testing the response to
thrombin (Fig. 2B). ANP increases the albumin permeability after
10 min in the 24-h skin wound (n = 12, P < 0.05; Friedman
multiple comparison test) to the same extent as previously
demonstrated in uninjured skin (Curry et al. 2010).
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increase permeability. This suggested the ANP increased
permeability was not associated with a local increase in
cAMP, but was more likely associated with decreased
intracellular cAMP as previously reported by Ladetzki-
Baehs et al. (2007). The fact that we found no evidence
that the endothelial barrier was stabilized by ANP,
taken with our previous observations that ANP attenu-
ated thrombin-induced PMN accumulation, indicated
that at least part of the action of ANP in attenuation
of thrombin-induced permeability increase depicted in
Figure 2 was attributable to a reduction in leukocyte/
endothelial interaction in the vasculature surrounding
the wound.
ANP reduces PMN numbers accessing the
wound
In 3 of the 12 experiments in Figure 3 we simultane-
ously measured EGFP-PMN fluorescence in the wound
of Lys-M-EGFP mice (515–575 nm window) and albu-
min permeability (>680 nm window). Likewise, Figure 4
depicts the change in fluorescence intensity measured
from PMN recruitment over a period of 120 min for
these three experiments plus two additional experiments
in which permeability was not measured (fluorescent
albumin was not present). In response to wounding and
in the absence of added ANP, the EGFP-PMN signal
was stable over the 30-min control. Following ANP
addition, the EGFP-PMN signal fell steadily over
90 min. The reduction in FI intensity in the presence of
ANP fell at a rate of‘ 5% per hour relative to the base-
line value. This decrease was significantly different from
the stable control level (0% per hour; P < 0.0001, F-
test). Thus, ANP acts to reduce the number of PMNs
recruited to the wound (Fig. 4) under the same condi-
tions as it acts to transiently increase vascular permeabil-
ity (Fig. 3). These data conform to the hypothesis that
the action of ANP to attenuate thrombin response
(Fig. 2) is primarily by reducing PMN-dependent mech-
anisms that increase permeability following their arrest
on endothelium and associated platelet activation (Kim
et al. 2009), rather than a primary action of stabilizing
the endothelial barrier.
Thirty minutes pretreatment with ANP does
not attenuate histamine activated acute
increases in vascular permeability in
individual microvessels of rat perfused
mesentery
To test if ANP modulated increased permeability when
leukocytes were absent, we measured Ps albumin in indi-
vidually perfused microvessels. In 16 microvessels
perfused with 1% BSA with added red cells, the baseline
permeability to albumin (595 Alexa label) was
4.3  0.6 9 107 cm/sec. Eight of the vessels were
exposed to 100 lmol/L histamine directly after control
measurements, and eight were exposed to ANP
(100 nmol/L) for 30 min followed by histamine and con-
tinued ANP. Figure 5 shows that pretreatment with ANP
did not attenuate the peak increase in albumin permeabil-
ity in response to histamine (P = 0.64, Mann–Whitney).
Chen et al. (2013) reported that the effectiveness of
ANP to attenuate histamine-induced increases in perme-
ability was potentiated by pretreatment with the PDE5
inhibitor sildenafil. Additional experiments with pretreat-
ment of the microvessels with both ANP and sildenafil
(1 lmol/L) did not change the response depicted in Fig-
ure 5. Moreover, the histamine response depicted in Fig-
ure 5 did not experience prolonged exposure to activated
PMNs. The maximum time the individual microvessels
were perfused was ~2 h. Histamine was used as an ago-
nist instead of thrombin because we have previously
reported that venular microvessels in rat mesentery only
respond to thrombin activation after 24 h of exposure to
inflammatory conditions. These experiments in individu-
ally perfused microvessels distinguish a role of ANP to
modulate an increase in permeability under conditions
where activated inflammatory cells are present for many
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Figure 4. Atrial natriuretic peptide (ANP) induces the FI intensity
from polymorphonuclear leukocytes (PMNs) in the skin wound to
fall by 5%/h when applied to the wound. This is significantly
greater than the result expected if ANP did not reduce PMN levels
(n = 5; P < 0.0001; F-test). We have previously demonstrated that
after the 30 min of such exposure, ANP also attenuates thrombin-
induced hyperpermeability (as in Fig. 2B). The results in Figure 4
taken with these previous observations confirm that ANP reduces
PMN accumulation in both the presence and absence of thrombin.
Note that the FI reflects signal from all PMNs (intravascular and
extravascular in the wound). To the extent that PMNs closely
associated with the endothelial cell surface are only a fraction of
the total PMNs, the fractional reduction in PMNs at the endothelial
surface is expected to be larger than 10%.
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hours (up to 24 h in our experiments). In contrast, the
acute responses in perfused microvessels measured under
conditions in which inflammatory cells are washed out of
the vessel lumen and the endothelium is the primary tar-
get that lacks any discernable response to the presence of
ANP.
Thirty minutes pretreatment with ANP does
not attenuate increased Lp with bradykinin
and histamine
In a final set of experiments, we tested the action of ANP
on acute increases in hydraulic conductivity (Lp) induced
by bradykinin and histamine. Here, we increased the con-
centration of ANP up to 1 lmol/L in order to match the
conditions on cultured endothelial cells (Furst et al.
2008). In five vessels with 30 min of ANP pretreatment
the mean baseline Lp was 0.65  0.06 9 107 cm/sec/
cmH2O and when exposed to bradykinin (10 nmol/L) the
Lp increased to a mean of 18.0  2.5 9 107 cm/sec/
cmH2O. In the absence of ANP the mean baseline Lp with
BSA was 0.76  0.13 9 107 cm/sec/cmH2O and Lp
increased to a peak value of 26.1  5.9 9 107 cm/sec/
cmH2O with bradykinin. Thus, as with measurements of
albumin permeability, there was no significant effect of
ANP to attenuate bradykinin (n = 5, P = 0.31; Wil-
coxon). Figure 6 shows a single representative experiment,
however, similar results were obtained using histamine in
two separate groups of vessels. In microvessels with simi-
lar baseline values for Lp as in Figure 6, the response to
histamine with ANP pretreatment (mean
14.3  5.7 9 107 cm/sec/cmH2O; n = 7) is not different
from the response in the absence of ANP (mean
12.2  3.2 9 107 cm/sec/cmH2O; n = 9) (P > 0.9,
Mann–Whitney test). Taken together, the data indicate
that ANP did not attenuate the transient increase in Lp
after exposure of the venular microvessels of rat mesen-
tery to bradykinin.
Discussion
We have demonstrated that after only 30 min pre-expo-
sure to ANP, the thrombin-induced increase in vascular
permeability is attenuated in a mouse skin wound. This
observation is consistent with previous reports that ANP
exerts an anti-inflammatory action in vasculature induced
to a high permeability state. The key new observations
here are that during the 30 min pre-exposure, ANP acts
in the 24 h wound via at least two different mechanisms.
On one hand, the well-established action of ANP, acting
via cGMP-dependent mechanisms (Joseph et al. 2013) to
increase vascular permeability to albumin is not signifi-
cantly modified in the wound compared with the normal
baseline state as demonstrated in Figure 3. On the other
hand, ANP causes a steady decrease in the number of
PMNs that accumulate in the wound in response to the
inflammation induced by the wound injury. When com-
bined with our previous observations that ANP reduces
thrombin-induced accumulation of PMNs in the 24 h
0
10
20
30
Ctrl Hist
w/ANP
Hist
Ps
 B
SA
 X
 1
0–
7  (
cm
/s
)
Figure 5. Atrial natriuretic peptide (ANP; 100 nmol/L) did not
attenuate the increase in apparent albumin permeability (measured
as peak response of Hist w/ANP relative to Hist alone) in response
to histamine in individually perfused rat mesentery microvessels
(n = 16 ctrl, n = 8 Hist w/ANP, n = 8 Hist, P = 0.64; Mann–
Whitney). The perfusate in these vessels was a standard Ringer-
albumin solution containing red cell (1.5% to ensure a stable
baseline permeability; Curry et al. 2012) but no polymorphonuclear
leukocytes.
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Figure 6. Representative experiment showing that atrial natriuretic
peptide at concentrations up to 1000 nmol/L (as used in in vitro
experiments) did not attenuate the increase in hydraulic
conductivity after exposure of rat venular microvessels to bradykinin
(10 nmol/L). The perfusate was as in Figure 5.
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skin wound, these observations support the conclusion
that the primary action of ANP under the conditions of
our experiment to attenuate the thrombin-induced
increase in permeability is not to stabilize the endothelial
barrier, but to modify PMN-dependent mechanisms stim-
ulated by thrombin that increase vascular permeability.
This result is consistent with our previous observations
that ANP has a striking action to decrease PMN deforma-
bility and thereby attenuate the rolling, arrest, and
transendothelial migration on cultured cell monolayers
(Morikis et al. 2015). Our investigations unify the results
of in vivo and in vitro investigations that point to the
potential for ANP to modulate inflammatory responses
by limiting PMN–endothelial interactions.
Our recently published in vitro investigations demon-
strated that ANP reduced PMN deformability and their
capacity to spread onto the endothelial surface. ANP
treatment was observed to increase PMN cytoplasmic vis-
cosity within minutes, whereas the subsurface membrane
cortical tension remained constant (Morikis et al. 2015).
Furthermore, single-cell image analysis of PMNs rolling
to arrest under fluid shear stress demonstrated a signifi-
cantly smaller adhesive contact area and diminished for-
mation of durable integrin bond clusters between
leukocytes and endothelium. Cellular mechanisms that
may modulate the reduced leukocyte deformability
include ANP signaling via GC-A receptors on leukocytes
that activate Rac GTPase and its effector PAK1, which in
turn downregulates GEF-H1 activation via phosphoryla-
tion at Ser855. One downstream consequence is reduced
activation of Rho-GTPases, which are key regulators of
actin dynamics in vascular cells (Damiano et al. 1996).
Additionally, ANP has been shown to stabilize micro-
tubules, leading to its vasoprotective effects (Tian et al.
2014). One or more of these mechanisms could account
for our observation that ANP reduced PMN accumula-
tion in the skin wound.
An important new result is that ANP does not have a
significant effect to attenuate the acute responses to his-
tamine and bradykinin when the perfusion conditions are
controlled such that resident leukocytes that may roll
along the vessel wall at the beginning of the experiment
are washed away and the number of attached leukocytes
is minimal (Curry et al. 2012). We tested ANP at concen-
trations up to 1000 nmol/L because experiments in cul-
tured endothelial monolayers had reported inhibition of
histamine-induced increases in permeability under these
conditions (Furst et al. 2008). Furthermore, continuous
perfusion of the microvessels in the absence of circulating
leukocytes is in contrast to the state of microvessels in
previous reports using mouse cremaster muscle (Furst
et al. 2008; Chen et al. 2013), which were continuously
exposed to circulating blood. Under these conditions
histamine is known to stimulate leukocyte–endothelial
interactions (Yamaki et al. 1998). These differences high-
light the need to evaluate mechanisms for the modulation
of vascular permeability modulation at multiple levels of
vascular organization. For example, they highlight impor-
tant new questions about the interpretation of results
under disparate experimental conditions.
Whereas our experiments revealed little action of ANP
on endothelium stimulated with histamine in the virtual
absence of leukocytes, previous investigators attributed a
nearly 50% reduction in peak permeability response to
the anti-inflammatory action of ANP on histamine-stimu-
lated endothelial cells. Thus, Furst et al. (2008) appear to
have ignored the contribution of ANP on leukocyte–en-
dothelial interaction. On the other hand, Chen et al.
(2013) demonstrated that the action of ANP to attenuate
the histamine response in cremaster muscle microvessels
was absent in mice with endothelium-specific deletion of
the cGMP generating GC-A receptor for ANP or the
endothelial cGMP-dependent protein Kinase 1 (cGKI).
Their data are clearly consistent with a significant action
of ANP in these two KO mouse models. It remains to be
determined if differences in the relative contribution of
endothelial- and leukocyte-dependent mechanisms can be
explained by differences in experimental conditions (cre-
master muscle vs. mesenteric venular vessel, FITC Dex-
tran vs. albumin as a permeability probe, the presence of
other blood components vs. Ringer with albumin and red
cells). In addition, it is important to note that the mice
lacking endothelial GC-A and cGKI were generated using
a Tie2/Cre-Lox approach in mouse hematopoietic cells,
an approach usually considered to enable endothelial-spe-
cific mechanisms assuming Tie2 is an endothelium-speci-
fic marker. However, the specificity of Tie2 promoters to
direct gene regulation only in endothelial cells has
recently been questioned because of the widespread
expression of Tie2 in other inflammatory cells of
hematopoietic origin including PMNs (Tang et al. 2010;
Joseph et al. 2013). Thus, recent investigations measuring
both leukocyte accumulation and endothelial cell response
in mice in Tie2-Cre mice point the way to further investi-
gations, especially if the responses of PMN to ANP under
the conditions of the experiments are suspect (Chen et al.
2016).
It is also noted that the same rat venular microves-
sels that respond to histamine and bradykinin do not
respond to thrombin in individually perfused microves-
sels (Curry et al. 2003). Thrombin causes increased per-
meability only after sustained exposure to inflammatory
conditions. The same result is found in mouse skin
(Kim et al. 2008). The present results indicate that this
response is likely to involve PMN-derived products
stimulated by thrombin.
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Our investigations do not rule out the possible action
of ANP on endothelium under different experimental
conditions. The observation of Beavo’s group that ANP-
dependent increases in cGMP may either increase or
decrease cAMP via cGMP-dependent phosphodiesterase
indicates that, depending on the relative expression levels
of these PDEs, ANP may exert either an increased perme-
ability by lowering intracellular cAMP or lowered perme-
ability when intracellular cAMP levels are increased
(Surapisitchat et al. 2007). Our observation that the
PDE4 inhibitor rolipram attenuated the ANP-induced
permeability can be explained if the action of rolipram to
independently increase cAMP overrides actions of ANP to
reduce cAMP levels under the conditions of our experi-
ments (Lin et al. 2012). Consistent with such an action of
ANP, we have demonstrated that mice lacking cAMP-
dependent Epac1 (Epac1/ mice) do not respond to
ANP through an increase in permeability but have ele-
vated baseline permeability (Kopperud et al. 2016). One
example of the way that changes in the expression level of
PDEs in endothelium modulates responses to ANP is the
observation that mice with EC-specific deletion of their
ANP receptor (GC-A) have mildly but significantly smal-
ler infarct size compared to control littermates (Chen
et al. 2016) after permanent ligation of the proximal part
of their left coronary artery. These authors show that
ANP may fail to protect the heart under these conditions
because, in response to TNF-a released in the heart after
the ligation, the expression levels of cAMP degrading
PDE2A are increased. The result is a lower level of cAMP
concentration close to the endothelial cell membrane in
the control animal (with endothelial ANP receptors) than
in the ANP receptor KO mice. Although endothelial
actions of ANP signaling appear to have been more
important than its action on PMN in these mouse models
(PMN accumulation after 2 days is similar in both con-
trol and KO mice), the levels of expression of the ANP
receptor on PMN in both KO and control littermates and
the way ANP modulates the interaction of these PMN
with endothelium has not been systematically investi-
gated.
We note that to make measurements of both perme-
ability and PMN accumulation under similar conditions
required the use of a combination of whole animal and
microperfusion experiments in rats and mice. No rat
model was available where the PMNs-expressing EGFP
could be used to quantify their accumulation under the
same conditions as permeability was measured and the
mouse tissues (mesentery and muscle) have very few
microvessels suitable for microperfusion. Furthermore, we
did not investigate acute responses to thrombin in per-
fused microvessels, as thrombin does not acutely increase
permeability in vessel that has not been exposed to
inflammatory conditions. Thus, in addition to our speci-
fic goal to investigate ANP-dependent regulation of vas-
cular permeability with and without the presence of
leukocytes, these investigations (in parallel with our
recent in vitro investigations) demonstrate some of the
current strengths and weaknesses of current strategies to
understand the modulation of vascular permeability at
the cellular, single microvessel, and whole microvascular
bed approaches.
On the basis of our results we predict that the effective-
ness of the vasoprotective actions of ANP likely depends
on the nature of the primary microvascular dysfunction
and activation state of the endothelium. ANP is not
expected to be protective when the primary insult is an
acute inflammatory agent which acts via mechanisms in
endothelium similar to histamine (calcium influx,
reduced endothelial cell adhesion, gap formation in
microvascular endothelial cells; Chen et al. 2013) and
where the net effect of ANP action in endothelial cells is
reduced submembrane cAMP levels. On the other hand,
ANP is expected to be more protective under conditions
in which leukocyte/endothelial interactions are promoted
and ANP modulation of leukocyte deformability effec-
tively reduces their accumulation. In experimental models
and in clinical situations both inflammatory stimuli are
likely to be present and the outcome dependent on which
ANP-dependent pathways modulate endothelium and
leukocytes.
Conclusion
The hypothesis that the anti-inflammatory actions of
ANP result solely from ANP ligation of endothelial recep-
tors that act to stabilize barrier function is not supported
by our results in either individually perfused microvessels
in the absence of circulating leukocytes, or the more
chronic skin wound model. Our results conform to an
alternate hypothesis that ANP modulates the interaction
of leukocytes with the microvascular wall in the inflam-
matory state of a 24 h wound. The action of ANP to
attenuate leukocyte–endothelial interactions and attenuate
a subsequent thrombin-induced permeability increase in
the presence of accumulated PMNs is corroborated by
our previous report that ANP decreases leukocyte
deformability, thereby reducing the adhesive contact area
and strength of attachment to endothelium. These obser-
vations provide the basis for additional investigations of
the use of ANP as an anti-inflammatory agent to modu-
late leukocyte–endothelial cell interactions.
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